Invests in companies that have the potential to transform the cell and gene therapy ecosystem, focusing on addressing bottlenecks in development and delivery to ensure access to innovative treatments for patients. Targets areas such as enabling technology platforms, raw materials, and solutions for affordable access to life-changing therapies.